Figures & data
Figure 1. Health gains and losses when NICE recommends a new health technology, assuming that a QALY is forgone by other NHS patients for every £13,000 spent on the technology.
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 17, 2017 - Issue 3
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement
Source:
Oxford University Press (OUP)
Linking provided by
